1.7(top 50%)
impact factor
47.6K(top 1%)
papers
775.8K(top 1%)
citations
298(top 1%)
h-index
1.8(top 50%)
impact factor
57.8K
all documents
820.5K
doc citations
457(top 1%)
g-index

Top Articles

#TitleJournalYearCitations
1Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013Annals of Oncology20132,805
2ESMO consensus guidelines for the management of patients with metastatic colorectal cancerAnnals of Oncology20162,545
3Estimates of the cancer incidence and mortality in Europe in 2006Annals of Oncology20072,332
4The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014Annals of Oncology20152,122
5Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology20171,744
6Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinicAnnals of Oncology20191,742
7Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology20181,571
8Prevalence of pain in patients with cancer: a systematic review of the past 40 yearsAnnals of Oncology20071,506
9Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology20171,456
10Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015Annals of Oncology20151,449
11Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancerAnnals of Oncology20041,407
12Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology20161,351
13Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology20191,241
14ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision makingAnnals of Oncology20121,233
15Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology20101,220
16Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology20161,212
17Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, ChinaAnnals of Oncology20201,188
18Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009Annals of Oncology20091,184
19Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology20151,168
20Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodiesAnnals of Oncology20151,136
21Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology20171,126
22Cancer incidence and mortality in Europe, 2004Annals of Oncology20051,046
23Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology20141,039
24Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trialAnnals of Oncology20141,022
25Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology20151,015
26Non-Invasive Analysis of Acquired Resistance to Cancer Therapy By Sequencing of Plasma DnaAnnals of Oncology2014987
27Heating the patient: a promising approach?Annals of Oncology2002983
28HER2 in gastric cancer: a new prognostic factor and a novel therapeutic targetAnnals of Oncology2008931
29Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologistsAnnals of Oncology2018915
30Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology2014910
31Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005Annals of Oncology2005909
32Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumabAnnals of Oncology2017908
33Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancerAnnals of Oncology2004900
34Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)Annals of Oncology2013895
354th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)Annals of Oncology2018891
36Use of complementary and alternative medicine in cancer patients: a European surveyAnnals of Oncology2005875
37Worldwide burden of cervical cancer in 2008Annals of Oncology2011875
38Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology2013874
393rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)Annals of Oncology2017865
40ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-upAnnals of Oncology2016862
41Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studiesAnnals of Oncology2014857
42De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017Annals of Oncology2017844
43Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registryAnnals of Oncology2019842
44Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology2016834
45Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology2013833
46Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007Annals of Oncology2007825
47Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC studyAnnals of Oncology2013792
48Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNAAnnals of Oncology2020770
49Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapyAnnals of Oncology2016765
505th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)Annals of Oncology2020761